Holding(s) in Company
February 21 2008 - 11:24AM
UK Regulatory
RNS Number:5111O
EiRx Therapeutics PLC
21 February 2008
TR-1: Notifications of Major Interests in Shares
Eirx Therapeutics Plc
1. Identity of the issuer or the underlying issuer of
existing shares to which voting rights are attached:
2. Reason for notification (yes/no)
YES
An acquisition or disposal of voting rights
NO
An acquisition or disposal of financial instruments which may result in the acquisition
of shares already issued to which voting rights are attached
NO
An event changing the breakdown of voting rights
NO
Other (please specify):______________
3. Full name of person(s) subject to notification Barclays PLC
obligation:
4. Full name of shareholder(s) (if different from Barclays Stockbrokers Ltd
3):
5. Date of transaction (and date on which the 18 February 2008
threshold is crossed or reached if different):
6. Date on which issuer notified: 19 February 2008
7. Threshold(s) that is/are crossed or reached: 5 % to 6%
8. Notified details: N/A
A: Voting rights attached to shares
Class/type of Situation previous to the Resulting situation after the triggering transaction
shares triggering transaction
Number of Number of Number of Number of voting rights Percentage of voting
If possible use shares voting shares rights
ISIN code rights
Direct Direct Indirect Direct Indirect
GB00B0XQBS97 162,562,668 162,562,668 187,968,924 0 187,968,924 0.00 6.32
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ conversion No. of voting rights Percentage of voting
instrument period/date that may be acquired rights
(if the instrument
exercised/converted)
N/A N/A N/A N/A N/A
Total (A+B)
Number of voting rights Percentage of voting rights
187,968,924 6.32
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively
held, if applicable:
Barclays Stockbrokers Ltd
Proxy Voting:
10. Name of proxy holder: N/A
11. Number of voting rights proxy holder will cease N/A
to hold:
12. Date on which proxy holder will cease to hold N/A
voting rights:
13. Additional information: N/A
14 Contact name: Geoff Smith
15. Contact telephone name: 0207 116 2913
For notes on how to complete form TR-1 please see the FSA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUAUNRWORUUAR
Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From Oct 2023 to Oct 2024